Additional file 1: Figure S1. of Clinical characteristics and outcomes according to age in lenalidomide-treated patients with RBC transfusion-dependent lower-risk MDS and del(5q)

Study populations in the MDS-003 and MDS-004 studies. Gray shaded boxes: age groups in the present analysis. LEN, lenalidomide. (DOCX 39 kb)